In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, Merck & Co Inc (NYSE: MRK) closed at $78.12 down -4.44% from its previous closing price of $81.75. In other words, the price has decreased by -$4.44 from its previous closing price. On the day, 19.78 million shares were traded. MRK stock price reached its highest trading level at $81.485 during the session, while it also had its lowest trading level at $77.855.
Ratios:
For a deeper understanding of Merck & Co Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.51. For the most recent quarter (mrq), Quick Ratio is recorded 1.16 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.69.
On April 22, 2025, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $85.
Deutsche Bank Downgraded its Buy to Hold on February 18, 2025, whereas the target price for the stock was revised from $128 to $105.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 25 ’25 when Smart Dalton E. III sold 4,262 shares for $82.76 per share. The transaction valued at 352,723 led to the insider holds 7,778 shares of the business.
DALTON SMART bought 4,262 shares of MRK for $352,723 on Apr 25 ’25. On Feb 19 ’25, another insider, Oosthuizen Johannes Jacobus, who serves as the President, U.S. Market of the company, sold 8,500 shares for $84.09 each. As a result, the insider received 714,745 and left with 30,705 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRK now has a Market Capitalization of 196161667072 and an Enterprise Value of 221842767872. As of this moment, Merck’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.04, and their Forward P/E ratio for the next fiscal year is 8.09. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.07. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.09 while its Price-to-Book (P/B) ratio in mrq is 4.07. Its current Enterprise Value per Revenue stands at 3.487 whereas that against EBITDA is 7.609.
Stock Price History:
The Beta on a monthly basis for MRK is 0.40, which has changed by -0.32187498 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, MRK has reached a high of $120.30, while it has fallen to a 52-week low of $73.31. The 50-Day Moving Average of the stock is -2.66%, while the 200-Day Moving Average is calculated to be -13.45%.
Shares Statistics:
For the past three months, MRK has traded an average of 15.12M shares per day and 13719010 over the past ten days. A total of 2.51B shares are outstanding, with a floating share count of 2.51B. Insiders hold about 0.06% of the company’s shares, while institutions hold 80.26% stake in the company. Shares short for MRK as of 1752537600 were 28773023 with a Short Ratio of 1.90, compared to 1749772800 on 35799415. Therefore, it implies a Short% of Shares Outstanding of 28773023 and a Short% of Float of 1.28.
Dividends & Splits
According to the company, the forward annual dividend rate for MRK is 3.20, from 3.16 in the trailing year. Against a Trailing Annual Dividend Yield of 0.038654435The stock’s 5-year Average Dividend Yield is 3.01. The current Payout Ratio is 46.32% for MRK, which recently paid a dividend on 2025-06-16 with an ex-dividend date of 2025-09-15. Stock splits for the company last occurred on 2021-06-03 when the company split stock in a 1048:1000 ratio.
